Immunohistochemistry demonstrated diffuse nuclear STAT6 and CD34 positivity, confirming SFT, with a low Ki-67 labeling index of 5%, and no necrosis or significant mitotic activity. The gene discussed is STAT6; the disease is solitary fibrous tumor.